Ready 8-Ks
50
Latest filing
June 5, 2026, 5:20 PM ET
Top materiality
0.85
Event mix
other_material ×17 · leadership ×15 · earnings ×14
Sentiment
9 pos · 10 neg · 31 neu
Latest earnings
reported 2026-Q1
-
Charlotte's Web co-founder Jared Stanley resigns from board to focus on DeFloria Phase 2 drug
Co-founder Jared Stanley resigned from Board on June 3, 2026 to become CEO of DeFloria, advancing its FDA Phase 2 botanical drug for autism irritability.
-
BAT converts C$75M debenture at C$0.94, invests US$10M, now owns 40.6% of Charlotte's Web
BAT invested US$10M (C$13.9M) for 14.66M common shares at C$0.94 each via private placement.
-
Charlotte's Web appoints BAT GC to board, closes debt conversion & US$10M investment
Appointed James Jeffery Raborn (EVP Law at Reynolds American/BAT) to board as BAT designee, effective May 28, 2026.
-
Charlotte's Web Q1 2026 revenue down 9% to $11.2M, net loss $13.1M, proposes BAT transaction to eliminate debenture
Revenue $11.2M vs $12.3M in Q1 2025; net loss includes $8.9M non-cash fair value charge on BAT convertible debenture.
-
BAT invests US$10M, converts C$75M debenture into ~40.8% stake in Charlotte's Web
BAT to purchase up to 14.76M common shares for US$10M (~C$13.9M) at minimum C$0.94/share.
-
BAT converts $65M debenture to equity, invests $10M; Charlotte's Web debt-free
Conversion of C$75.3M principal plus C$14.2M accrued interest into ~95M shares at C$0.94 per share.
-
Charlotte's Web Q4 rev $13.3M (+4.7% YoY), net loss $11.5M; announces BAT debenture conversion & CMMI pilot
Q4 2025 revenue $13.3M, up 4.7% YoY; net loss $11.5M ($0.07 loss per share).
-
Charlotte's Web Q3 revenue $11.5M (-8.6% YoY); net loss $5.9M; targets $9M cost savings in 2026
Revenue $11.5M vs $12.6M in Q3 2024; gross margin 38.9% (down from 53%) due to $0.5M B2B chargeback reserve and in-house manufacturing ramp.
-
Charlotte’s Web posts Q1 2025 revenue of $12.3M, first YoY growth since 2021; net loss narrows to $6.2M
Revenue $12.3M +1.1% YoY (first growth since Q2 2021); SG&A down 24.2%.
-
Charlotte's Web Q4 2024 revenue $12.7M; positive Adj. EBITDA $0.3M; full-year loss narrows
Q4 revenue $12.7M (down 20% YoY) but sequentially up from $12.6M in Q3 2024.
-
Charlotte's Web Q3 revenue $12.6M (-12% YoY); net loss narrows to $5.8M
Revenue $12.6M vs $14.3M YoY; net loss $5.8M ($0.04/sh) compared to $15.2M ($0.10) in Q3 2023.
-
Charlotte's Web Q2 revenue $12.3M, net loss $11.0M; cuts costs, launches new e-commerce platform
Revenue $12.3M, down 23% YoY; net loss $11.0M ($0.07/sh) vs income $2.8M in Q2 2023.
-
Charlotte's Web Q1 revenue falls 29% to $12.1M; net loss widens to $9.7M
Revenue $12.1M (down 29% YoY); net loss $9.7M vs $2.9M loss in Q1 2023.
-
Charlotte's Web Q4 net loss $8.5M; FY revenue down 14.8% to $63.2M, launches True North turnaround
Q4 2023 revenue $15.9M (-16% YoY); gross profit $8.9M (56% margin); net loss $8.5M ($0.06/share).
-
Charlotte's Web extends MLB deal to 2027 ($23M fee), adds ex-Ben & Jerry's CEO to board
MLB partnership extended to Dec 31, 2027 with aggregate rights fee of $23M for the remainder of the term.
-
Charlotte's Web Q3 revenue falls 16% to $14.3M; net loss widens to $15.2M; new CEO appointed
Q3 revenue $14.3M, down from $17.0M YoY; net loss $15.2M ($0.10/share) vs $7.6M ($0.05).
-
Charlotte's Web appoints Bill Morachnick as CEO; Tortoroli departs
William Morachnick named CEO and non-independent director effective Sept 13, 2023, replacing Jacques Tortoroli.
-
Charlotte's Web Q2 revenue falls 15% to $16M; net income $2.8M (non-cash) but adjusted EBITDA loss widens
Revenue $16.0M vs $18.9M YoY (-15%); gross margin improved to 55.7% from 49.4%.
-
Four Charlotte's Web directors receive only ~33% support; offer resignations per policy
Directors Held, Lardieri, Morga, Tortoroli each received ≈33% votes for, ≈67% withheld at June 15 AGM.
-
Charlotte's Web board rejects Stanley demand to replace independent directors ahead of June 15 meeting
Joel and Jesse Stanley demanded replacement of majority of board within 48 hours; board refuses.
-
Charlotte's Web Q1 revenue falls 12.1% to $17M; net loss narrows to $2.9M
Revenue $17.0M, down 12.1% YoY from $19.4M; driven by lower oil tincture volume and mix shift to gummies.
-
Charlotte's Web forms JV with BAT and AJNA to develop FDA-approved hemp botanical drug
BAT invests $10M for 20% preferred equity; Charlotte's Web and AJNA each hold 40% voting common.
-
Charlotte's Web Q4 2022 revenue down 23.8% to $18.9M; net loss $35.2M
Full-year 2022 revenue $74.1M (down 22.8% YoY); net loss $59.3M vs $137.7M in 2021.
-
Charlotte's Web names Jessica Saxton CFO effective Jan 1, 2023; Greg Gould departs Dec 31
Jessica Saxton appointed CFO effective Jan 1, 2023, succeeding Greg Gould, who departs Dec 31, 2022 without disagreement.
-
Charlotte's Web closes ~$56.8M convertible debenture with BAT subsidiary; convertible into 19.9% stake at C$2.00/share
Investment of US$56.8M (C$75.3M) from BT DE Investments, wholly owned by British American Tobacco (NYSE: BTI).